Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace
Protara Therapeutics (Nasdaq: TARA) was named a BioSpace 2026 Best Places to Work winner on November 4, 2025.
The company received the award in BioSpace’s small employer category and is one of 50 U.S. employers recognized (20 large, 30 small). Protara highlighted its Flatiron District, New York City office, a collaborative culture, competitive benefits, and emphasis on professional development, inclusivity, and work-life balance.
Management framed the award as recognition of employee commitment to advancing Protara’s clinical-stage programs in cancer and rare diseases and invited interest via the company careers page.
Protara Therapeutics (Nasdaq: TARA) è stata nominata una BioSpace 2026 Best Places to Work vincitrice il 4 novembre 2025.
L'azienda ha ricevuto il premio nella categoria piccolo datore di lavoro ed è una delle 50 aziende statunitensi riconosciute (20 grandi, 30 piccoli). Protara ha sottolineato il proprio ufficio nel Flatiron District, New York City, una cultura collaborativa, benefici competitivi e l'enfasi sullo sviluppo professionale, l'inclusione e l'equilibrio tra lavoro e vita privata.
La direzione ha inquadrato il premio come riconoscimento dell'impegno dei dipendenti nel progresso dei programmi clinici di Protara in oncologia e malattie rare e ha invitato a manifestare interesse tramite la pagina delle carriere dell'azienda.
Protara Therapeutics (Nasdaq: TARA) fue galardonada como BioSpace 2026 Best Places to Work el 4 de noviembre de 2025.
La empresa recibió el premio en la categoría de pequeño empleador y es una de las 50 empresas estadounidenses reconocidas (20 grandes, 30 pequeñas). Protara destacó su oficina en el distrito Flatiron, Ciudad de Nueva York, una cultura colaborativa, beneficios competitivos y énfasis en el desarrollo profesional, la inclusión y el equilibrio entre trabajo y vida personal.
La dirección enmarcó el premio como reconocimiento al compromiso de los empleados con el avance de los programas clínicos de Protara en oncología y enfermedades raras e invitó a interesarse a través de la página de carreras de la empresa.
Protara Therapeutics (나스닥: TARA)가 2025년 11월 4일 BioSpace 2026 Best Places to Work 수상자로 이름지워졌습니다.
회사는 소기업 부문에서 상을 받았으며 50개의 미국 고용주 중 하나로 인정받았습니다(대기업 20곳, 소기업 30곳). 프로타라(Flatiron District, 뉴욕시) 사무실, 협력적 문화, 경쟁력 있는 혜택, 전문성 개발, 포용성 및 일과 삶의 균형에 대한 강조를 강조했습니다.
경영진은 이 상을 직원들이 암 및 희귀 질환에서 프로타라의 임상 단계 프로그램을 발전시키려는 헌신의 인정으로 보았고, 회사 채용 페이지를 통해 관심을 환영했습니다.
Protara Therapeutics (NYSE: TARA) a été nommée gagnante du BioSpace 2026 Best Places to Work le 4 novembre 2025.
L'entreprise a reçu le prix dans la catégorie petit employeur et figure parmi les 50 employeurs américains reconnus (20 grands, 30 petits). Protara a mis en avant son bureau dans le Flatiron District, à New York, une culture collaborative, des prestations compétitives et un accent sur le développement professionnel, l'inclusion et l'équilibre travail-vie personnelle.
La direction a qualifié le prix de reconnaissance de l'engagement des employés à faire progresser les programmes cliniques de Protara dans le domaine du cancer et des maladies rares et a invité les intéressés à consulter la page carrières de l'entreprise.
Protara Therapeutics (Nasdaq: TARA) wurde am 4. November 2025 als BioSpace 2026 Best Places to Work ausgezeichnet.
Das Unternehmen erhielt die Auszeichnung in der Kategorie Kleiner Arbeitgeber und gehört zu den 50 anerkannten US-Arbeitgebern (20 große, 30 kleine). Protara hob sein Büro im Flatiron District, New York City, hervor, eine kollaborative Kultur, wettbewerbsfähige Leistungen und den Schwerpunkt auf berufliche Entwicklung, Inklusion und Work-Life-Balance.
Das Management interpretierte die Auszeichnung als Anerkennung des Engagements der Mitarbeitenden für die Weiterentwicklung von Protaras klinischen Programmen im Bereich Krebs und seltener Erkrankungen und lud Interessierte über die Karriereseite des Unternehmens ein.
Protara Therapeutics (ناسداك: TARA) تم اختيارها كفائزة BioSpace 2026 Best Places to Work في 4 نوفمبر 2025.
تلقت الشركة الجائزة في فئة صاحب العمل الصغير وتُعد واحدة من 50 صاحب عمل في الولايات المتحدة معترف بهم (20 كبير، 30 صغير). أبرزت Protara مكتبها في منطقة Flatiron District بولاية نيويورك، وثقافة تعاونية، ومزايا تنافسية، وتركيز على التطوير المهني، والشمول، والتوازن بين العمل والحياة.
ثم عبرت الإدارة عن أن الجائزة تعد اعترافاً بالتزام الموظفين بتقدم برامج Protara السريرية في مجال السرطان والأمراض النادرة ودعت إلى إبداء الاهتمام عبر صفحة وظائف الشركة.
- None.
- None.
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that it has been named a BioSpace 2026 Best Place to Work.
“Protara is thrilled to be recognized as one of the most sought-after biotech employers in the life sciences community,” said Jesse Shefferman, Chief Executive Officer of Protara Therapeutics. “Our colleagues are crucial to every aspect of our success, and this award is a reflection of our team’s commitment to fostering a vibrant culture that attracts top talent and inspires team members to make a meaningful impact. I would like to thank all of our colleagues for their continued hard work and dedication to developing transformative therapies to patients.”
Protara is among 50 U.S. employers on BioSpace’s Best Places to Work list, with 20 organizations ranked in large and 30 ranked in small employer categories. Protara received the award in the small employer category.
Located in the Flatiron District of New York City, Protara has a modern and collaborative working environment where integrity, tenacity and teamwork are highly valued. The Company has competitive benefits and prioritizes professional development, inclusivity and work-life balance. Learn more about a career at Protara: https://protaratx.com/careers/
About Best Places to Work
Nominations for Best Places to Work were open in June, 2025. Voting was conducted in August, 2025. BioSpace reviewed the votes and rankings submitted by over 7,500 life sciences professionals. Respondents were asked to identify their top three most desirable biopharma companies, segmented by large (more than 1,000+ employees) and small (less than 1,000 employees) companies. Respondents were also asked to rate their top choice organization on attributes including: compensation, innovation, career growth opportunities, leadership, culture, diversity, equity and inclusion, reputation, and flexibility and remote work.
About Protara Therapeutics, Inc.
Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead candidate, TARA-002, an investigational cell-based therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). The Company is evaluating TARA-002 in an ongoing Phase 2 trial in NMIBC patients with carcinoma in situ (CIS) who are unresponsive or naïve to treatment with Bacillus Calmette-Guérin (BCG), as well as a Phase 2 trial in pediatric patients with LMs. Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral nutrition who are otherwise unable to meet their choline needs via oral or enteral routes. For more information, visit www.protaratx.com.
Company Contact:
Justine O'Malley
Protara Therapeutics
Justine.OMalley@protaratx.com
646-817-2836
FAQ
What award did Protara Therapeutics (TARA) win on November 4, 2025?
How many companies were named to BioSpace’s Best Places to Work list when Protara (TARA) was recognized?
Why did Protara Therapeutics (TARA) say the BioSpace award matters?
Where is Protara Therapeutics (TARA) headquartered and what workplace traits did it highlight?
Will the BioSpace award affect hiring at Protara (TARA)?
Where can applicants find Protara (TARA) job listings after the BioSpace recognition?
